National Bank of Canada FI Buys 70,100 Shares of Amedisys, Inc. (NASDAQ:AMED)

National Bank of Canada FI raised its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 96.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 142,434 shares of the health services provider’s stock after acquiring an additional 70,100 shares during the quarter. National Bank of Canada FI owned approximately 0.44% of Amedisys worth $13,527,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Calamos Advisors LLC bought a new stake in shares of Amedisys during the fourth quarter worth $23,015,000. SG Americas Securities LLC increased its position in Amedisys by 181.1% in the 4th quarter. SG Americas Securities LLC now owns 63,953 shares of the health services provider’s stock valued at $6,079,000 after acquiring an additional 41,206 shares in the last quarter. Wolverine Asset Management LLC raised its stake in shares of Amedisys by 13.9% in the fourth quarter. Wolverine Asset Management LLC now owns 35,181 shares of the health services provider’s stock worth $3,344,000 after acquiring an additional 4,299 shares during the last quarter. Bank of Nova Scotia acquired a new position in shares of Amedisys during the third quarter worth approximately $26,671,000. Finally, Hsbc Holdings PLC grew its stake in shares of Amedisys by 184.9% during the third quarter. Hsbc Holdings PLC now owns 110,479 shares of the health services provider’s stock valued at $10,327,000 after purchasing an additional 71,705 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Stock Up 1.9 %

Shares of AMED stock opened at $94.08 on Thursday. The firm’s fifty day moving average price is $92.32 and its two-hundred day moving average price is $93.33. Amedisys, Inc. has a 1 year low of $73.10 and a 1 year high of $96.44. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $3.07 billion, a P/E ratio of -147.00, a PEG ratio of 3.43 and a beta of 0.84.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. The company had revenue of $571.41 million for the quarter, compared to analysts’ expectations of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The business’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.00 EPS. On average, equities analysts predict that Amedisys, Inc. will post 4.57 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have issued reports on AMED. Raymond James restated a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 target price on shares of Amedisys in a report on Thursday, April 25th. StockNews.com raised Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Royal Bank of Canada upped their price objective on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, March 25th. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $100.80.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.